Prof. Ján Kyselovič, Pharm.D., PhD

Last update: 23. 10. 2023

I. BASIC INFORMATION
I.1 Surname Kyselovič
I.2 Name Ján
I.3 Titles Prof. , Pharm.D., PhD
I.4 Year of birth 1963
I.5 Name of the workplace University of Veterinary Medicine and Pharmacy in Košice, Department of Pharmacology and Toxicology
I.6 Address of the workplace Komenského 73, 041 81 Košice, Slovak Republic
I.7 Position professor
I.8 E-mail address jan.kyselovic@uvlf.sk
I.9 Hyperlink to the entry of a person in the Register of university staff https://www.portalvs.sk/regzam/detail/3738
I.10 Name of the study field in which a person works at the university pharmacy
I.11 ORCID iD 3 https://orcid.org/0000-0001-9208-5352
3 Optional item.

II. HIGHER EDUCATION AND FURTHER QUALIFICATION GROWTH
II.a Name of the university or institution II.b Year II.c Study field and programme
II.1 First degree of higher education
II.2 Second degree of higher education Comenius University in Bratislava, Faculty of Pharmacy 1987 clinical pharmacy
II.3 Third degree of higher education Commenius University in Bratislava, Faculty of Medicine 1993 pharmacology
II.4 Associate professor Comenius University in Bratislava, Faculty of Pharmacy 2003 pharmacology
II.5 Professor Comenius University in Bratislava, Faculty of Pharmacy 2009 pharmacology
II.6 Doctor of Science (DrSc.)

III. CURRENT AND PREVIOUS EMPLOYMENT
III.a Occupation-position III.b Institution III.c Duration
professor University of veterinary medicine and pharmacy in Košice 2021 up to now
researcher Faculty of Medicine, Commenius University, Bratislava 2017 up to now
assistant University of veterinary medicine and pharmacy in Košice 2014 2021
professor Faculty of Medicine, Commenius University, Bratislava 2013 2015
professor Faculty of Pharmacy, Comenius University in Bratislava 2009 2017
assotiate professor Faculty of Pharmacy, Comenius University in Bratislava 2003 2009
assistant Faculty of Pharmacy, Comenius University in Bratislava 1992 2003

IV. DEVELOPMENT OF PEDAGOGICAL, PROFESSIONAL, LANGUAGE, DIGITAL AND OTHER SKILLS
IV.a Activity description, course name, other IV.b Name of the institution IV.c Year
visiting scientist Research unit, Sainte Justine nemocnica, Montreal, Canada 2004
visiting scientist Department of Pharmacology and Toxicology, UCL Brussels, Belgium 1996
postgradual study stay MDAC in Pharmacology Medical Faculty, Department Pharmacology, University of Ottawa, Canada 1993
study stay - grant MRC of Canada Medical Faculty, Department Pharmacology, University of Ottawa, Canada 1992

V. OVERVIEW OF ACTIVITIES WITHIN THE TEACHING CAREER AT THE UNIVERSITY
V.1. Overview of the profile courses taught in the current academic year according to study programmes
V.1.a Name of the profile course V.1.b Study programme V.1.c Degree V.1.d Field of study
Clinical pharmacology and pharmacotherapypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy
Pharmacologypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy

V.2. Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year 4
V.2.a Study programme V.2.b Degree V.2.d Field of study
pharmacy full time slovak language combined 1st and 2nd pharmacy
pharmacy (join study programme) full time slovak language combined 1st and 2nd pharmacy
4 According to Art. 6 para. 4 of the Standards for the Study Programme.

V.3. Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.3.a Name of the field of habilitation procedure and inaugural procedure V.3.b Study field to which it is assigned

V.4. Overview of supervised final theses
V.4.a Bachelor's (first degree) V.4.b Diploma (second degree) V.4.c Dissertation (third degree)
V.4.1 Number of currently supervised theses 0 2 1
V.4.2 Number of defended theses 10 124 8

V.5. Overview of other courses taught in the current academic year according to study programmes
V.5.a Name of the course V.5.b Study programme V.5.c Degree V.5.d Field of study
Pharmacologypharmacy (join study programme) full time slovak languagecombined 1st and 2ndpharmacy

VI. OVERVIEW OF THE RESEARCH/ARTISTIC/OTHER OUTPUTS
VI.1. Overview of the research/artistic/other outputs and the corresponding citations
VI.1.a Overall VI.1.b Over the last six years
VI.1.1 Number of the research/artictic/other outputs 759
VI.1.2 Number of the research/artictic/other outputs registered in the Web of Science or Scopus databases 134
VI.1.3 Number of citations corresponding to the research/artictic/other outputs 1169
VI.1.4 Number of citations registered in the Web of Science or Scopus databases 1364
VI.1.5 Number of invited lectures at the international, national level 1 1

VI.2. The most significant research/artistic/other outputs 5
1. Kyselovič, Ján - Leddy, J. J. - Ray, A. - Wigle, J. - Tuana, B. S.: Temporal differences in the induction of dihydropyridine receptor subunits and ryanodine receptors during skeletal muscle development In: Journal of Biological Chemistry. - Vol. 269, No. 34 (1994), s. 21770-21777. - ISSN 0021-9258 Indikátor časopisu: IF (JCR) 1994=7,716 SCI citácie 40
2. Kyselovič, Ján - Martinka, Peter - Baťová, Zuzana - Gažová, Andrea [UKOLFFAU] - Godfraind, Theophile: Calcium channel blocker inhibits western-type diet-evoked atherosclerosis development in apoE-deficient mice(S) In: Journal of Pharmacology and Experimental Therapeutics. - Vol. 315, No. 1 (2005), s. 320-328. - ISSN 0022-3565, IF (JCR) 2005=4,098 SCI citácie 30
3. Kyselovič, Ján - Morel, Nicol - Wibo, Maurice - Godfraind, Theophile: Prevention of Salt-Dependent Cardiac Remodeling and Enhanced Gene Expression in Stroke-Prone Hypertensive Rats by the Long-Acting Calcium Channel Blocker Lacidipine, In: Journal of Hypertension. - Vol. 16, No. 10 (1998), s. 1515-1522. - ISSN 0263-6352 Indikátor časopisu: IF (JCR) 1998=3,065 SCI citácie 15
4. Kyselovič, Ján - Křenek, Peter - Wibo, Maurice - Godfraind, Theophile: Effects of amlodipine and lacidipine on cardiac remodelling and renin production in salt-loaded stroke-prone hypertensive rats . In: British Journal of Pharmacology. - Vol. 134, No. 7 (2001), s. 1516-1522. - ISSN 0007-1188 Indikátor časopisu: IF (JCR) 2001=3,502 SCI citácie 35
5. Křenek, Peter- Kmecová, Jana - Kučerová, Dana - Bajuszová, Zuzana - Musil, Peter - Gažová, Andrea - Ochodnický, Peter- Klimas, Ján - Kyselovič, Ján Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function. European Journal of Heart Failure. - Vol. 11, No. 2 (2009), s. 140-146. - ISSN (print) 1388-9842 IF (JCR) 2009=3,70 SCI citácie 86
5 Maximum of five most significant outputs, if the RATP form is attached to the application.

VI.3. The most significant research/artistic/other outputs over the last six years 6
1. Gao, Feng- Kataoka, Masaharu - Liu, Ning - Liang, Tian - Huang, Zhan-Peng - Gu, Fei - Ding, Jian - Liu, Jianming - Zhang, Feng - Ma, Qing - Wang, Yingchao - Zhang, Mingming - Hu, Xiaoyun - Kyselovič, Ján - Hu, Xinyang - Pu, William T. - Wang, Jian/'an - Chen, Jinghai - Wang, Da-Zhi: Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction In: Nature Communications [elektronický dokument]. - Roč. 10, č. 1 (2019), s. [1-15], Art. No. 1802 [online]. - ISSN (online) 2041-1723 IF (JCR) 2019=12,121 Ohlasy (94)
2. Polakovičová, Mája- Musil, Peter- Laczo, Eugen - Hamar, Dušan - Kyselovič, Ján: Circulating microRNAs as potential biomarkers of exercise response Lit. 130 zázn. In: International journal of molecular sciences [elektronický dokument]. - Roč. 17, č. 10, č. čl. 1553, (2016), s. 1-20. - ISSN (online) 1422-0067 IF (JCR) 2016=3,226 SCI citácie: 66
3. Straka, Igor - Minár, Michal - Gažová, Andrea - Valkovič, Peter - Kyselovič, Ján: Clinical aspects of adherence to pharmacotherapy in Parkinson disease: APRISMA-compliant systematic review. In: Medicine [elektronický dokument]. - Roč. 97, č. 23 (2018), s. [1-6], art. no. e10962 [print]. - ISSN (print) 0025-7974 IF (JCR) 2018=1,870 SCI citácie 22
4. Adamičková, Adriana - Gažová, Andrea- Chomaničová, Nikola - Valášková, Simona- Juríková, Miroslava- Kyselovič, Ján: The pi3k/Akt pathway isassociated with angiogenesis, oxidative stress and survival of mesenchymal stem cells in pathophysiologic condition in ischemia In: Physiological research. - Roč. 68, č. Supplement 2 (2019), s. S131-S138. - ISSN (print) 0862-8408 IF (JCR) 2019=1,655 SCI 31
5. Kyselovič, Ján [UKOLF5IK] (25%) - Koščová, Eva (25%) - Lampert, Anette (25%) - Weiser, Thomas [KAUT] (25%): A randomized, double-blind, placebo-controlled trial of ibuprofen lysinate in comparison to ibuprofen acid for acute postoperative dentalpain [elektronický dokument] In: Pain and Therapy [elektronický dokument]. - Roč. 9, č. 1 (2020), s. 249-259 [online]. - ISSN (online) 2193-651X IF (JCR) 2020=5,725 SCi citácie 5
6 Maximum of five most significant outputs over the last six years, if the RATP form is attached to the application.

VI.4. The most significant citations corresponding to the research/artistic/other outputs 7
1. Kyselovic et al. JBC 1994: citícia 1999 Spitz, F. - Demignon, J. - Kahn, A. - Daegelen, D. - Maire, P.: Journal of Molecular Biology, vol. 289, no. 4, 1999, s. 893-903
2. Kyselovic et al. JPET 2005: citácia 2009 Van Hove, C.E. - Van Der Donckt, C. - Herman, A.G. - Bult, H. - Fransen, P.: British Journal of Pharmacology, vol. 158, no. 3, 2009, s. 920-930
3. Krenek .....Kyselovic: European Journal of Heart Failure.2009: citácia: 2021 Junho, C.V.C. - Azevedo, C.A.B. - da Cunha, R.S. - de Yurre, A.R. - Medei, E. - Stinghen, A.E.M. - Carneiro-Ramos, M.S.: Cells, vol. 10, no. 8, 2021, art. no. 1939 -
4. Gao, ...Kyselovic.. Wnag et al. citácia 2021 Wu, Y. - Zhou, L. - Liu, H. - Duan, R. - Zhou, H. - Zhang, F. - He, X. - Lu, D. - Xiong, K. - Xiong, M. - Zhuang, J. - Liu, Y. - Li, L. - Liang, D. - Chen, Y.H.: Cell Research, vol. 31, no. 4, 2021, s. 450-462
5. Polakovicova....Kyselovic et al. 2016 citácia: 2020 Jeremic, N. - Weber, G.J. - Theilen, N.T. - Tyagi, S.C.: Journal of Cellular Physiology, vol. 235, no. 6, 2020, s. 5229-5240 - SCI
7 Maximum of five most significant citations, if the RATP form is attached to the application.

VI.5. Participation in conducting (leading) the most important research projects or art projects over the last six years 8
1. 2017- 2019 MZ SR 2016/13-FAUK-1 Synergický regeneračný potenciál farmakologickej intervencie do transkripčných signálnych dráh v transplantovaných kmeňových bunkách a reprogramovaných fibroblastoch v ischemickom myokarde
2. 2019-2022 Sanofi Aventis O-18-101/0001- 00 Evaluation of Magnesium bioavailability/bioaccessibility from different Magnesium salts using the human intestinal epithelial Caco-2 cell line model.
3. 2016-2018 2016/13-FAUK-Synergický regeneračný potenciál farmakologickej intervencie do transkripčných signálních dráh v transplantovaných kmeňových bunkách a reprogramovaných fibroblastoch v ischemickom myokarde, CARDIOSTEM
4. 2015-2019 APVV-14-0416 Regenerative potential of pharmacological intervetion to the GATA4, HAND2, MEF2C and TBX5 signal pathways in cell based therapy of cardiovascular diseases.
5. 2019 - 2022 APVV-Covid20-0101: Systém na telemedicínsku diagnostiku klinického stavu pacientov s COVID-19 a iných ochorení s príbuznými príznakmi pre minimalizáciu dopadov pandémie
8 Maximum of five most significant projects, if the RATP form is attached to the application. In addition to the name and brief characteristics of the project, the type of participation is indicated (in Slovak and in English), if possible, a hyperlink to the project and its outputs and citations are stated as well.

VII. OVERVIEW OF ORGANIZATIONAL EXPERIENCE RELATED TO HIGHER EDUCATION AND RESEARCH/ARTISTIC/OTHER ACTIVITIES 9
VII.a Activity, position VII.b Name of the institution, board VII.c Duration
EU expert for Inovative medicine EMA EMA , Lomdon, Great Britain 2012 2018
Guarantor and chairman of the doctoral study department 7.1.30 Pharmacology Faculty of Pharmacy, Comenius University in Bratislava 2010 2017
Garant MSc study Farmacy Faculty of Pharmacy, Comenius University in Bratislava 2010 2017
member of Scietifical Board 2010 up to now
Dean of Faculty Faculty of Pharmacy, Comenius University in Bratislava 2009 2013
9 E.g. academic positions, memberships in editorial boards and in scientific and professional societies.

VIII. OVERVIEW OF INTERNATIONAL MOBILITIES AND VISITS ORIENTED ON EDUCATION AND RESEARCH/ARTISTIC/ OTHER ACTIVITIES IN THE GIVEN FIELD OF STUDY
VIII.a Name of the institution VIII.b Address of the institution VIII.c Duration (indicate the duration of stay) VIII.d Mobility scheme, employment contract, other (describe)
Research Centre, Sainte Justine Hospital Montreal, Canada 2004 2004 visiting scientist
Dept. Pharmacology and toxicology, Catholic University of Louvain, UCL, Brusselles, Belgium Dept. Pharmacology and toxicology Brusseles, Belgium 1996 2001 visiting scientist
Department Pharmacology Medical Faculty University of Ottawa, Canada 1993 1994 postgradual study stay MDAC in Pharmacology
Department Pharmacology Medical Faculty University of Ottawa, Canada 1992 1992 study stay - grant MRC of Canada

IX. OTHER RELEVANT FACTS 10
IX.a If relevant, other activities related to higher education or research/artictic/other activities are mentioned
1. 1985 Award of Slovak Academic of Science: “The best student science work” 2. 2013 Award Slovak Pharmaceutical Society 3. 2013 Award of FaF UK Hradec Králové 4. 2015 - 2017 Member of the Men's Health EU Advisory Board, 1989 present Member of Slovak Pharmacological Society, 5. 2014 present Member of British Pharmacological Society 6. 2016 present Member American Heart Association (AHA) 7. 2016 present Member the American Association for the Advancement of Science (AAAS)
10 Maximum of 1800 characters, if the RATP form is attached to the application.
Skip to content